Alpha 2.0
Login Register
» Authors » R Parslew

R Parslew

Explore the profile of R Parslew including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 371
Followers 0
Related Specialties
Dermatology
General Medicine
General Surgery
Top 10 Co-Authors
C H Smith
A D Burden
R Murphy
P S Friedmann
R B Warren
J L Verbov
C M Owen
C E M Griffiths
M F Mohd Mustapa
G R Sharpe
Published In
Br J Dermatol
Clin Exp Dermatol
Plast Reconstr Surg
Contact Dermatitis
Acta Derm Venereol
Affiliations
Soon will be listed here.
Recent Articles
1.
Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)
Cro S, Cornelius V, Pink A, Wilson R, Pushpa-Rajah A, Patel P, et al.
Br J Dermatol . 2021 Aug; PMID: 34411292
Background: Palmoplantar pustulosis (PPP) is a rare, debilitating, chronic inflammatory skin disease that affects the hands and feet. Clinical, immunological and genetic findings suggest a pathogenic role for interleukin (IL)-1....
2.
A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine
Lavery M, Nawimana S, Parslew R, Stewart L
Clin Exp Dermatol . 2021 Apr; 46(7):1325-1327. PMID: 33914926
No abstract available.
3.
Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis
Mahil S, Ezejimofor M, Exton L, Manounah L, Burden A, Coates L, et al.
Br J Dermatol . 2020 Jun; 183(4):638-649. PMID: 32562551
Background: The rapid expansion of psoriasis biologics has led to an urgent need to understand their relative efficacy and tolerability to inform treatment decisions better and, specifically, to inform guideline...
4.
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update
Smith C, Yiu Z, Bale T, Burden A, Coates L, Edwards W, et al.
Br J Dermatol . 2020 Mar; 183(4):628-637. PMID: 32189327
No abstract available.
5.
Localized cluster of nodules in childhood
Wong J, Khirwadkar N, Parslew R
Clin Exp Dermatol . 2017 Oct; 43(1):88-90. PMID: 29058336
No abstract available.
6.
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017
Smith C, Jabbar-Lopez Z, Yiu Z, Bale T, Burden A, Coates L, et al.
Br J Dermatol . 2017 May; 177(3):628-636. PMID: 28513835
No abstract available.
7.
A rare cause of mucositis
Trehan P, Pang E, Khirwadkar N, Alsharqi A, Parslew R
Clin Exp Dermatol . 2016 Oct; 41(8):951-952. PMID: 27757972
No abstract available.
8.
Identification of loci associated with late-onset psoriasis using dense genotyping of immune-related regions
Hebert H, Bowes J, Smith R, Flynn E, Parslew R, Alsharqi A, et al.
Br J Dermatol . 2014 Aug; 172(4):933-9. PMID: 25124732
Background: Chronic plaque psoriasis can be subdivided into two groups according to the age of onset: type 1 (early onset, before 40 years) and type 2 (late onset, at or...
9.
A case of tumour necrosis factor-α inhibitor- and rituximab-induced plantar pustular psoriasis that completely resolved with tocilizumab
Jayasekera P, Parslew R, Al-Sharqi A
Br J Dermatol . 2014 Jun; 171(6):1546-9. PMID: 24890762
Rituximab, a chimeric B-cell-depleting monoclonal antibody, is a well-established therapy for rheumatoid arthritis. It is emerging that classical psoriatic lesions and plantar pustular psoriasis (PPP) are cutaneous side-effects of this...
10.
Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland
Laws P, Downs A, Parslew R, Dever B, Smith C, Barker J, et al.
Br J Dermatol . 2011 Sep; 166(1):189-95. PMID: 21929536
Background: There are limited data on the use of ustekinumab outside of clinical trials. Objectives: To assess the efficacy and safety of ustekinumab in patients with severe psoriasis attending 10...